tug of war, money

Despite weathering a difficult year, biopharma continues to see massive pay gaps between CEOs and their median employees, with top executives often earning hundreds of times more.

Biogen

The company announced today that it had agreed to buy privately held Human Immunology Biosciences for up to $1.8 billion, bulking up on rare disease medicines as its older multiple sclerosis drugs face tepid demand due to rising competition.

A large fire that broke out at a Novo Nordisk office building in Denmark on Wednesday has been brought under control, the local fire department said.

The experimental drug was in development to treat agitation and restlessness caused by symptoms of Alzheimer’s disease.

Spectrum Science

In her new role, Hutnik will lead Spectrum’s global platform of integrated services including enterprise- wide operations and growth planning across the company’s four strategic pillars: Scientific Communications, Advertising & Consulting, Clinical Trial Experience and Spectrum Science Europe.

Great progress has been made in the management of female infertility since the introduction of assisted reproductive technology, predominantly in vitro fertilization (IVF). However, despite the improvements made in the space, challenges associated with the treatment remain. The development of non-injectable fertility medications represents a significant unmet need, reports GlobalData.